Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.50p
   
  • Change Today:
      0.25p
  • 52 Week High: 16.50
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 116,614
  • Market Cap: £18.19m
  • RiskGrade: 429

Deal with Barclays    Trade now with Barclays Stockbrokers

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 7.50p
Change Today 0.25p
% Change 3.45 %
52 Week High 16.50
52 Week Low 5.75
Volume 116,614
Shares Issued 242.54m
Market Cap £18.19m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.39% below the market average35.39% below the market average35.39% below the market average35.39% below the market average35.39% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
49.88% below the market average49.88% below the market average49.88% below the market average49.88% below the market average49.88% below the market average
5.45% below the sector average5.45% below the sector average5.45% below the sector average5.45% below the sector average5.45% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 07-May-2024

Time Volume / Share Price
16:07 25,000 @ 7.50p
15:09 4,860 @ 7.95p
14:24 45 @ 7.00p
13:38 2,232 @ 7.27p
11:48 15,000 @ 7.95p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page